Is ACAD or VKTX more profitable?

ACAD runs the higher net margin — ACAD at 33.42% versus VKTX at 0.00%.

How have ACAD and VKTX total returns compared?

Over the past 10 years, ACAD delivered -3.53% and VKTX delivered 35.25% annualized total return. Past performance doesn't predict future results.

Acadia Pharmaceuticals Inc. (ACAD) vs Viking Therapeutics, Inc. (VKTX)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and Viking Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACAD

Acadia Pharmaceuticals Inc.

$3.38B

$19.74HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VKTX

Viking Therapeutics, Inc.

$3.31B

$28.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ACAD vs VKTX

growth of $100 · dividends reinvested · last 10y

ACAD -36.8% (-4.5%/yr)VKTX +2152.3% (+36.5%/yr)VKTX compounded faster over this window

Log scale — wide-divergence pair

ACAD VKTX

ACAD vs VKTX: by the numbers

•ACAD is the larger company ($3.38B vs $3.31B market cap).
•ACAD is profitable (33.42% net margin) while VKTX runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	ACAD	VKTX
P/E ratio	8.89	N/A
Forward P/E	32.05	N/A
P/S ratio	2.97	N/A
P/B ratio	2.59	8.11
EV / EBITDA	31.19	N/A
FCF yield	5.16%	N/A

Profitability

Metric	ACAD	VKTX
Gross margin	91.13%	0.00%
Operating margin	7.59%	0.00%
Net margin	33.42%	0.00%
ROE	29.12%	-130.98%
ROIC	6.25%	-135.85%

Growth (annualized)

Metric	ACAD	VKTX
Revenue CAGR (5Y)	19.70%	N/A
Total return CAGR (5Y)	3.52%	37.36%

Frequently asked

Is ACAD or VKTX more profitable?: ACAD runs the higher net margin — ACAD at 33.42% versus VKTX at 0.00%.
How have ACAD and VKTX total returns compared?: Over the past 10 years, ACAD delivered -3.53% and VKTX delivered 35.25% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACAD analysis Full VKTX analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio Acadia Pharmaceuticals ROE Viking Therapeutics ROE Acadia Pharmaceuticals operating margin Viking Therapeutics operating margin Acadia Pharmaceuticals revenue growth Viking Therapeutics revenue growth Acadia Pharmaceuticals free cash flow Viking Therapeutics free cash flow

Acadia Pharmaceuticals & Viking Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.